| 000 | 01845 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515021531.0 | ||
| 264 | 0 | _c20060626 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a0012-1797 | ||
| 024 | 7 |
_a10.2337/diabetes.55.04.06.db05-0676 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJaziri, Riphed | |
| 245 | 0 | 0 |
_aThe PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study. _h[electronic resource] |
| 260 |
_bDiabetes _cApr 2006 |
||
| 300 |
_a1157-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdiponectin _xgenetics |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAlanine |
| 650 | 0 | 4 | _aAmino Acid Substitution |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xepidemiology |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperglycemia _xepidemiology |
| 650 | 0 | 4 |
_aHyperinsulinism _xepidemiology |
| 650 | 0 | 4 |
_aInsulin Resistance _xgenetics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPPAR gamma _xgenetics |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aProline |
| 700 | 1 | _aLobbens, Stephane | |
| 700 | 1 | _aAubert, Roberte | |
| 700 | 1 | _aPéan, Franck | |
| 700 | 1 | _aLahmidi, Saida | |
| 700 | 1 | _aVaxillaire, Martine | |
| 700 | 1 | _aPorchay, Isabelle | |
| 700 | 1 | _aBellili, Naïma | |
| 700 | 1 | _aTichet, Jean | |
| 700 | 1 | _aBalkau, Beverley | |
| 700 | 1 | _aFroguel, Philippe | |
| 700 | 1 | _aMarre, Michel | |
| 700 | 1 | _aFumeron, Frédéric | |
| 773 | 0 |
_tDiabetes _gvol. 55 _gno. 4 _gp. 1157-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/diabetes.55.04.06.db05-0676 _zAvailable from publisher's website |
| 999 |
_c16174867 _d16174867 |
||